Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors Read more
NiKang Therapeutics Announces Completion of $200 Million Series C Financing to Advance Highly Differentiated Small Molecules Addressing Difficult-to-Drug Targets Read more
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech Read more
Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite Read more
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases Read more
Boehringer Ingelheim’s Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation Read more
Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery Read more
Libtayo (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers Read more